Why the study?
Traditional chemotherapy for ovarian cancer has limitations including poor curative effects, systemic toxicity, and drug resistance, prompting exploration of an innovative method to enhance clinical efficiency.
Does codelivery of chloroquine and doxorubicin by MPEG-PLA nanoparticles enhance anticancer effects in ovarian cancer models?
Population
Doxorubicin-resistant and wild-type A2780/SKOV3 cells and nude mice model
Comparison
Nanoparticle-encapsulated chloroquine and chemotherapeutic drugs vs free drug delivery
Design
Preclinical in vitro and in vivo laboratory study
Authors
Loading...
Preclinical nanoplatform shows targeted ovarian cancer activity; leaves open clinical translation and safety validation.
Does codelivery of chloroquine and doxorubicin by MPEG-PLA nanoparticles enhance anticancer effects in ovarian cancer models?
Codelivery of chloroquine and doxorubicin via MPEG-PLA nanoparticles enhances anticancer efficacy and reduces systemic toxicity in preclinical ovarian cancer models.
Shao et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: